If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

Total Voting Rights

30 Jun 2011 07:00

RNS Number : 2477J
Ultima Networks PLC
30 June 2011
 

30 June 2011

 

Ultima Networks plc

("Ultima" or the "Company")

 

Total Voting Rights

 

The Board of Ultima announces that for the purpose of the Financial Services Authority's Disclosure and Transparency Rules, the total issued share capital in the Company at the date of this announcement consists of 279,176,538 ordinary shares of 1 pence each, each carrying the right to one vote.

 

The total number of voting rights in the Company is therefore 279,176,538.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

For further information, please contact:

 

Ultima Networks plc

Tel: 01279 821 200

David Nuttall, Company Secretary

 

Allenby Capital Limited (nominated adviser and broker)

Tel: 0203 328 5656

Nick Naylor

Nick Athanas

Dan Robinson

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRPGUBWQUPGURR
Date   Source Headline
24th Feb 20212:00 pmRNSPrice Monitoring Extension
24th Feb 202111:05 amRNSSecond Price Monitoring Extn
24th Feb 202111:00 amRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSFinal Results
11th Feb 20214:41 pmRNSSecond Price Monitoring Extn
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20212:05 pmRNSSecond Price Monitoring Extn
11th Feb 20212:00 pmRNSPrice Monitoring Extension
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 202110:30 amRNSNotification of Intention to Grant Patent
2nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:36 pmRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSTotal Voting Rights
14th Dec 20208:01 amRNSHolding(s) in Company
14th Dec 20208:01 amRNSHolding(s) in Company
9th Dec 20208:10 amRNSPlacing to raise £2 million
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
7th Dec 20204:36 pmRNSPrice Monitoring Extension
4th Dec 202011:06 amRNSSecond Price Monitoring Extn
4th Dec 202011:00 amRNSPrice Monitoring Extension
4th Dec 20209:05 amRNSSecond Price Monitoring Extn
4th Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20204:41 pmRNSSecond Price Monitoring Extn
3rd Dec 20204:35 pmRNSPrice Monitoring Extension
3rd Dec 20202:06 pmRNSSecond Price Monitoring Extn
3rd Dec 20202:01 pmRNSPrice Monitoring Extension
3rd Dec 202011:05 amRNSSecond Price Monitoring Extn
3rd Dec 202011:00 amRNSPrice Monitoring Extension
3rd Dec 20209:06 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSFormulation Work Update
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:36 pmRNSPrice Monitoring Extension
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:00 pmRNSPrice Monitoring Extension
18th Nov 20202:06 pmRNSSecond Price Monitoring Extn
18th Nov 20202:00 pmRNSPrice Monitoring Extension
18th Nov 202011:05 amRNSSecond Price Monitoring Extn
18th Nov 202011:00 amRNSPrice Monitoring Extension
18th Nov 20209:15 amRNSSP Angel Research Note
16th Nov 20202:06 pmRNSSecond Price Monitoring Extn
16th Nov 20202:01 pmRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
11th Nov 20204:41 pmRNSSecond Price Monitoring Extn
11th Nov 20204:35 pmRNSPrice Monitoring Extension
11th Nov 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.